Cancer Research · 2019 · 22 citations · 41 references
MedicineGeneticsOncologyCancer GeneticsDrug DiscoveryMolecular OncologyMelanoma PharmacotherapyReceptor Tyrosine Kinase OncogenesSignal Transduction In CancerTargeted Cancer TherapyTherapeutic ResistanceTyrosine Kinase InhibitorsAnticancer Drug ResistanceBraf V600 MutationsKinase Inhibitor ResistanceKinase Mutation-mediated ResistanceMapk SignalingResistance To Targeted TherapyResistance To Tyrosine Kinase InhibitorsTherapeutic Resistance Mechanisms
mutation. Unfortunately, the majority of patients eventually develop drug-resistant disease. We employed a genetic screening approach to identify gain-of-function mechanisms of BRAFi resistance in two independent melanoma cell lines. Our screens identified both known and unappreciated drivers of BRAFi resistance, including multiple members of the DBL family. Mechanistic studies identified a DBL/RAC1/PAK signaling axis capable of driving resistance to both current and next-generation BRAFis. However, we show that the SRC inhibitor, saracatinib, can block the DBL-driven resistance. Our work highlights the utility of our straightforward genetic screening method in identifying new drug combinations to combat acquired BRAFi resistance. SIGNIFICANCE: A simple, rapid, and flexible genetic screening approach identifies genes that drive resistance to MAPK inhibitors when overexpressed in human melanoma cells.
41
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem, Neville E. Sanjana, Ella Hartenian et al. · Science · 2013 · 5.5K citations · Full text
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Silvana Konermann, Mark D. Brigham, Alexandro E. Trevino et al. · Nature · 2014 · 2.9K citations
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text
Medicine, Oncology, Pharmacotherapy +14